Literature DB >> 29466829

Gender and quality of life in myasthenia gravis patients from the myasthenia gravis foundation of America registry.

Ikjae Lee1, Henry J Kaminski2, Haichang Xin3, Gary Cutter4.   

Abstract

INTRODUCTION: Quality of life (QOL) has been poorly characterized among patients with myasthenia gravis (MG) other than assessments performed within the clinical setting.
METHODS: Patients age ≥ 18 years who were diagnosed with MG and registered with the MG patient registry between July 1, 2013, and June 30, 2016, were included. Demographic information, disease related history, and QOL were compared between men and women using multivariable analysis.
RESULTS: A total of 1,315 subjects (827 women) were included. Women were significantly younger, had a younger age at symptom onset, and were more likely to have thymoma and thymectomy. The 15-item Myasthenia Gravis Quality of Life scale (MG-QOL15) was significantly worse in women. MG-QOL15 score was comparable between women who had thymectomy and men with or without thymectomy. DISCUSSION: QOL among MG patients is worse in women compared with men, but this disparity is eliminated in women who have undergone thymectomy. Muscle Nerve, 2018.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  MG-QOL15; MGFA registry; gender; myasthenia gravis; quality of life; thymectomy

Year:  2018        PMID: 29466829     DOI: 10.1002/mus.26104

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  5 in total

1.  Cross-sectional analysis of the Myasthenia Gravis Patient Registry: Disability and treatment.

Authors:  Gary Cutter; Haichang Xin; Inmaculada Aban; Ted M Burns; Phillip H Allman; Ramin Farzaneh-Far; Petra W Duda; Henry J Kaminski
Journal:  Muscle Nerve       Date:  2019-10-09       Impact factor: 3.217

2.  Quality of Life in Myasthenia Gravis and Correlation of MG-QOL15 with Other Functional Scales.

Authors:  Laura Diez Porras; Christian Homedes; Maria Antonia Alberti; Valentina Velez Santamaria; Carlos Casasnovas
Journal:  J Clin Med       Date:  2022-04-14       Impact factor: 4.964

Review 3.  Corticosteroid Treatment-Resistance in Myasthenia Gravis.

Authors:  Henry J Kaminski; Jordan Denk
Journal:  Front Neurol       Date:  2022-04-25       Impact factor: 4.086

4.  Gender differences in prednisone adverse effects: Survey result from the MG registry.

Authors:  Ikjae Lee; Henry J Kaminski; Tarrant McPherson; Michelle Feese; Gary Cutter
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2018-10-15

5.  Employment in refractory myasthenia gravis: A Myasthenia Gravis Foundation of America Registry analysis.

Authors:  Linda Harris; Inmaculada B Aban; Haichang Xin; Gary Cutter
Journal:  Muscle Nerve       Date:  2019-10-22       Impact factor: 3.217

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.